RT10

RETATRUTIDE

A TRIPLE-AGONIST PEPTIDE

Retatrutide is an investigational metabolic peptide currently being studied in clinical research for its interaction with multiple hormone pathways involved in appetite signalling, energy balance, and metabolic regulation. Interest in retatrutide has grown rapidly as researchers explore how triple-agonist peptides may influence hunger signalling and long-term bodyweight regulation.

Unlike earlier incretin-based peptides that activate a single metabolic pathway, retatrutide simultaneously interacts with GLP-1, GIP, and glucagon receptors. Because these signalling systems play a key role in appetite control, nutrient metabolism, and energy expenditure, triple-agonist peptides have become an important focus in modern weight-management research.

Early clinical research has drawn significant attention to retatrutide due to its broad metabolic signalling profile and the role triple-receptor peptides may play in future obesity and metabolic studies